4//SEC Filing
Smith Mark Burnham 4
Accession 0001209191-21-021963
CIK 0001733257other
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 9:31 PM ET
Size
5.6 KB
Accession
0001209191-21-021963
Insider Transaction Report
Form 4
Smith Mark Burnham
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option (right to buy)
2021-03-18+595,402→ 595,402 totalExercise: $17.00Exp: 2031-03-17→ Common Stock (595,402 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the shares subject to the option vest on March 18, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.
Documents
Issuer
Finch Therapeutics Group, Inc.
CIK 0001733257
Entity typeother
Related Parties
1- filerCIK 0001850293
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 9:31 PM ET
- Size
- 5.6 KB